老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stealth Biotherapeutics Corp

0.3200
0.0000
成交量：- -
成交额：41.97万
市值：2,353.68万
市盈率：-0.35
高：0.3200
开：0.3200
低：0.3200
收：0.3200
52周最高：1.17
52周最低：0.1621
股本：7,355.25万
流通股本：3,012.40万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-0.9237
每股收益(LYR):-0.9237
净资产收益率：1027.89%
总资产收益率：-67.24%
市净率：-0.52
市盈率(LYR):-0.35

数据加载中...

总览公司新闻公告
2021/04/06

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/22

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/05/07

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/01

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/16

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多